Yeji

$BMEA

Biomea Fusion, Inc.

Runway:11 mo
NasdaqMarket cap: —CIK 0001840439

Upcoming catalysts

0 surfaced

No catalysts surfaced for BMEA yet.

Drug pipeline

icovamenib 100 mg
Type 2 Diabetes
BMF-219
Non Small Cell Lung Cancer
BMF-500
Acute Myeloid Leukemia
Icovamenib
Healthy Volunteer
BMF-650
Obesity
icovamenib 100mg
Type 2 Diabetes

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT07502495icovamenib 100mgPhase 2Recruiting2027-06-01
NCT07502508icovamenib 100 mgPhase 2Recruiting2027-06-01
NCT07223216BMF-650Phase 1Active Not Recruiting2026-05-01
NCT05918692BMF-500Phase 1Active Not Recruiting2026-04-01
NCT07254286IcovamenibPhase 1Completed2026-01-14
NCT06152042BMF-219Phase 2Terminated2025-05-20
NCT05153330BMF-219Phase 1Terminated2025-02-13
NCT05631574BMF-219Phase 1Terminated2025-01-15
NCT05731544BMF-219Phase 2Completed2024-11-18